These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8177922)

  • 21. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release.
    Ishizu K; Smith DF; Bender D; Danielsen E; Hansen SB; Wong DF; Cumming P; Gjedde A
    Synapse; 2000 Oct; 38(1):87-101. PubMed ID: 10941144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
    Sonsalla PK; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
    Sekine Y; Minabe Y; Ouchi Y; Takei N; Iyo M; Nakamura K; Suzuki K; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Mori N
    Am J Psychiatry; 2003 Sep; 160(9):1699-701. PubMed ID: 12944350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
    Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
    Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone.
    Leysen JE; van Gompel P; Gommeren W; Laduron PM
    Psychopharmacol Ser; 1987; 3():214-24. PubMed ID: 2950521
    [No Abstract]   [Full Text] [Related]  

  • 27. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
    Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
    Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.
    Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K
    Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732
    [No Abstract]   [Full Text] [Related]  

  • 29. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
    Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Angrist B; Gatley SJ; Logan J; Ding YS; Pappas N
    Am J Psychiatry; 1999 Jan; 156(1):19-26. PubMed ID: 9892293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
    Robertson CL; Ishibashi K; Chudzynski J; Mooney LJ; Rawson RA; Dolezal BA; Cooper CB; Brown AK; Mandelkern MA; London ED
    Neuropsychopharmacology; 2016 May; 41(6):1629-36. PubMed ID: 26503310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
    Okita K; Ghahremani DG; Payer DE; Robertson CL; Dean AC; Mandelkern MA; London ED
    Drug Alcohol Depend; 2016 Apr; 161():163-70. PubMed ID: 26880595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D
    Pfeifer P; Tüscher O; Buchholz HG; Gründer G; Vernaleken I; Paulzen M; Zimmermann US; Maus S; Lieb K; Eggermann T; Fehr C; Schreckenberger M
    Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Age-related decrease of 11C-N-methylspiperone in vivo binding to human striatum detected by PET].
    Iyo M; Yamasaki T; Fukuda H; Inoue O; Suzuki K; Shinotoh H; Ito T; Yonezawa H; Nishio M; Koseki A
    Kaku Igaku; 1989 Feb; 26(2):213-20. PubMed ID: 2525202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol.
    Liskowsky DR; Potter LT
    Neuropharmacology; 1987 May; 26(5):481-3. PubMed ID: 2955242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.